About picard medical inc - PMI
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.
PMI At a Glance
Picard Medical, Inc.
1992 East Silverlake
Tucson, Arizona 85713
| Phone | 1-520-545-1234 | Revenue | 4.94M | |
| Industry | Medical Specialties | Net Income | -27,002,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 12.503% | |
| Fiscal Year-end | 12 / 2026 | Employees | 75 | |
| View SEC Filings |
PMI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 26.109 |
| Price to Book Ratio | 34.04 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -9.769 |
| Enterprise Value to Sales | 25.203 |
| Total Debt to Enterprise Value | 0.056 |
PMI Efficiency
| Revenue/Employee | 65,866.667 |
| Income Per Employee | -360,026.667 |
| Receivables Turnover | 6.526 |
| Total Asset Turnover | 0.281 |
PMI Liquidity
| Current Ratio | 1.109 |
| Quick Ratio | 0.718 |
| Cash Ratio | 0.613 |
PMI Profitability
| Gross Margin | -5.121 |
| Operating Margin | -268.36 |
| Pretax Margin | -545.891 |
| Net Margin | -546.599 |
| Return on Assets | -153.608 |
| Return on Equity | N/A |
| Return on Total Capital | -250.855 |
| Return on Invested Capital | N/A |
PMI Capital Structure
| Total Debt to Total Equity | 184.086 |
| Total Debt to Total Capital | 64.799 |
| Total Debt to Total Assets | 30.669 |
| Long-Term Debt to Equity | 1.689 |
| Long-Term Debt to Total Capital | 0.595 |